A comprehensive update of ICET-a network on COVID-19 in thalassemias: What we know and where we stand

Vincenzo de Sanctis*, Duran Canatan, Joan Lluis Vives Corrons, Mehran Karimi, Shahina Daar, Christos Kattamis, Ashraf T. Soliman, Yasser Wali, Salam Alkindi, Valeh Huseynov, Afag Nasibova, Tarık Onur Tiryaki, Melike Sezgin Evim, Adalet Meral Gunes, Zeynep Karakas, Soteroula Christou, Mohamed A. Yassin, Maria Concetta Galati, Saveria Campisi, Tahereh ZareiDoaa Khater, Yesim Oymak, Valeriya Kaleva, Denka Stoyanova, Atanas Banchev, Myrto Skafida, Yurdanur Kilinc

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of COVID-19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations. (www.actabiomedica.it).

Original languageEnglish
Article numbere2020026
Pages (from-to)1-7
Number of pages7
JournalActa Biomedica
Issue number3
Publication statusPublished - Sep 11 2020
Externally publishedYes


  • Associated co-morbidities
  • Clinical outcome
  • COVID-19 pandemic
  • Iron overload
  • Thalassemias
  • Update

ASJC Scopus subject areas

  • Medicine(all)

Cite this